top of page


Did you know that Nobel Prize winners are more likely to be involved in the arts in comparison to less accomplished scientists? In fact, a recent study found that cross-disciplinary arts involvement was 7 to 22 times higher in Nobel laureates than among other scientists. That includes the benefits of practicing music, drawing, painting, writing, and performing on a regular basis.

 Artist &Vice President of BD at Can-Fite BioPharma

The future no longer holds a space for an artificial divide between art and science. We must bring the two together. In fact, it’s woven into the very fabric of our culture.


Sari works in an Israeli Biotech company for the past 13 years.

Can-Fite BioPharma (NYSE MKT: CANF) (TASE:CFBI) is a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases.

Her abstraction art is her language to employ colors and shapes with different mediums and techniques. She explores her art like a scientist, enjoy the freedom of creativity and balance between her work and her art, combining them together with endless love.

Ph.D. - Bar-Ilan University

MA - Art Therapy, Haifa

Curatorship - Shorashim Art School, Tel-Aviv

Photography - Camera Obscura, Tel-Aviv & Muza, Herzliya

2 Published Books

10 Scientific Articles

Directors and Senior Management, IDC Herzliya

Pottery - Rachel Kadmor, Herzliya

 Dance Teacher in her past

Biology & Art - Ramat-Hasharom School

Clinical Project Management Diploma

Effective Clinical Trials: Design, Statistics and Reporting

GCP Course for Clinical Research Investigators

UCLA : Business

Can-Fite’s liver drug Namodenoson (CF102) is currently in a Phase II trial for patients with advanced liver cancer.

Due to water contamination in China, the prevalence of Liver Cancer is very high, the "Factory of the World" is getting lots of money, but poising the people!!!




by Dr. Sari Fishman

bottom of page